BioPharmX Corporation BPMX
No live quote for BPMX yet.
- Market cap
- 776.82K
- Forward P/E
- -2.22
- Volume
- 4.04M
- Avg volume
- 1.62M
- Open
- 0.5016
- Previous close
- 0.5635
- Analysts
- Hold
- Price target
- 2.25
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 6.12
- 200-day average
- 0.898736
Analyst view
Consensus: hold
Hold
Price target (mean) 2.25
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy0
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 14, 2016 | Maxim Group | init | — | Buy |
| Apr 7, 2016 | H.C. Wainwright | init | — | Buy |
| Sep 4, 2015 | Sterne Agee CRT | init | — | Buy |
News
Your note
Sign in to keep a note on BPMX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| KRAMMER ANJA B | Director | Sale | Jan 22, 2019 | 1,884,130 |
| MORLOCK STEPHEN | Director | Sale | Oct 21, 2018 | 0 |
| TARDIMED SCIENCES LLC | Beneficial Owner of more than 10% of a Class of Security | Sale | Feb 9, 2020 | 0 |
| TIMBER PHARMACEUTICALS LLC | Beneficial Owner of more than 10% of a Class of Security | Sale | Feb 9, 2020 | 2,200,330 |
| VIVO CAPITAL VIII LLC | Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 24, 2019 | 0 |